Measuring the Response of Extrahepatic Symptoms and Quality of Life to Antiviral Treatment in Patients with Hepatitis C

Keyphrases

• Quality of Life 100%
• Health-related Quality of Life 100%
• Hepatitis C 100%
• Antiviral Treatment 100%
• Sicca Syndrome 75%
• Chronic Pain 50%
• Mental Health 25%
• Patient-completed 25%
• Little Data 25%
• Physical Disability 25%
• Patient Cohort 25%
• Social Health 25%
• Social Functioning 25%
• Hepatitis 25%
• HCV Infection 25%
• General Health 25%
• Treatment Effect 25%
• Sustained Virological Response 25%
• HCV Antivirals 25%
• Hepatitis C Virus 25%
• Remission 25%
• Mixed Cryoglobulinemia 25%
• Positive Well-being 25%
• Ribavirin 25%
• Musculoskeletal Manifestations 25%
• Pegylated Interferon 25%
• Physical Functioning 25%
• Symptomatic Improvement 25%
• Polyarthritis 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Symptom 100%
• Antivirus Agent 100%
• Hepatitis C 100%
• Sjoegren Syndrome 75%
• Prevalence 50%
• Infection 25%
• Deterioration 25%
• Ribavirin 25%
• Polyarthritis 25%
• Peginterferon 25%
• Remission 25%
• Cryoglobulinemia 25%
• Hepatitis C Virus 25%
• Physical Disability 25%

Immunology and Microbiology

• Sjögren's Syndrome 100%
• Hepatitis C 100%
• Prevalence 66%
• Pegylated Interferon 33%
• Polyarthritis 33%
• Hepatitis C Virus 33%
• Ribavirin 33%
• Cryoglobulinemia 33%
• Wellbeing 33%
• Mental Health 33%